$AGX
ARGAN INC

2015 Q2 Form 10-Q Financial Statement

#000119312515216633 Filed on June 09, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2015 Q1 2014 Q2
Revenue $85.50M $102.3M $51.19M
YoY Change 67.02% 72.0% 9.74%
Cost Of Revenue $64.32M $80.60M $41.14M
YoY Change 56.35% 107.73% 22.37%
Gross Profit $21.17M $21.68M $10.05M
YoY Change 110.6% 4.78% -22.85%
Gross Profit Margin 24.76% 21.18% 19.63%
Selling, General & Admin $5.540M $6.100M $3.379M
YoY Change 63.95% 41.86% -1.86%
% of Gross Profit 26.17% 28.14% 33.62%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $119.0K $200.0K $142.0K
YoY Change -16.2% 100.0% 10.08%
% of Gross Profit 0.56% 0.92% 1.41%
Operating Expenses $5.540M $6.200M $3.379M
YoY Change 63.95% 44.19% -1.86%
Operating Profit $15.63M $15.47M $6.672M
YoY Change 134.22% -5.57% -30.39%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $85.00K $100.0K $22.00K
YoY Change 286.36% 0.0% -85.81%
Pretax Income $15.71M $15.60M $6.694M
YoY Change 134.72% -5.45% -38.36%
Income Tax $4.861M $5.700M $1.894M
% Of Pretax Income 30.94% 36.54% 28.29%
Net Earnings $7.503M $5.998M $3.475M
YoY Change 115.91% -34.55% -45.79%
Net Earnings / Revenue 8.78% 5.86% 6.79%
Basic Earnings Per Share $0.51 $0.41 $0.24
Diluted Earnings Per Share $0.50 $0.40 $0.24
COMMON SHARES
Basic Shares Outstanding 14.64M shares 14.30M shares
Diluted Shares Outstanding 14.86M shares 14.68M shares

Balance Sheet

Concept 2015 Q2 2015 Q1 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $330.5M $333.7M $313.8M
YoY Change 5.32% 22.59% 85.24%
Cash & Equivalents $274.5M $333.7M $313.8M
Short-Term Investments $56.00M
Other Short-Term Assets $4.300M $1.100M $2.312M
YoY Change 85.99% 191.78% -67.89%
Inventory $600.0K $500.0K $200.0K
Prepaid Expenses $1.092M $2.749M
Receivables $34.50M $27.33M $28.68M
Other Receivables $2.000M $1.800M $0.00
Total Short-Term Assets $372.0M $364.4M $347.7M
YoY Change 6.99% 22.04% 76.5%
LONG-TERM ASSETS
Property, Plant & Equipment $7.606M $6.518M $4.107M
YoY Change 85.2% 55.82% -44.5%
Goodwill $18.48M $18.48M $18.48M
YoY Change 0.0% 0.0% 0.0%
Intangibles $1.785M $1.845M $2.028M
YoY Change -11.98% -11.64%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $27.87M $26.84M $24.61M
YoY Change 13.23% 8.45% -13.91%
TOTAL ASSETS
Total Short-Term Assets $372.0M $364.4M $347.7M
Total Long-Term Assets $27.87M $26.84M $24.61M
Total Assets $399.9M $391.2M $372.3M
YoY Change 7.4% 21.0% 65.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $29.91M $37.69M $25.68M
YoY Change 16.5% 66.86% -9.91%
Accrued Expenses $19.06M $15.98M $3.630M
YoY Change 425.1% 101.92% -60.11%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $212.4M $215.4M $207.6M
YoY Change 2.3% 30.38% 109.74%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $212.4M $215.4M $207.6M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $212.8M $216.2M $208.0M
YoY Change 2.31% 30.64% 112.69%
SHAREHOLDERS EQUITY
Retained Earnings $81.12M $73.61M $56.81M
YoY Change 42.79% 38.02%
Common Stock $113.1M $111.9M $104.7M
YoY Change 8.02% 8.63%
Preferred Stock
YoY Change
Treasury Stock (at cost) $33.00K $33.00K $33.00K
YoY Change 0.0% 0.0%
Treasury Stock Shares 3.233K shares 3.233K shares 3.233K shares
Shareholders Equity $194.2M $185.5M $161.5M
YoY Change
Total Liabilities & Shareholders Equity $399.9M $391.2M $372.3M
YoY Change 7.4% 21.0% 65.03%

Cashflow Statement

Concept 2015 Q2 2015 Q1 2014 Q2
OPERATING ACTIVITIES
Net Income $7.503M $5.998M $3.475M
YoY Change 115.91% -34.55% -45.79%
Depreciation, Depletion And Amortization $119.0K $200.0K $142.0K
YoY Change -16.2% 100.0% 10.08%
Cash From Operating Activities -$2.290M $6.900M $40.54M
YoY Change -105.65% -90.18% -1240.9%
INVESTING ACTIVITIES
Capital Expenditures $1.207M -$1.100M $46.00K
YoY Change 2523.91% 450.0% -93.27%
Acquisitions
YoY Change
Other Investing Activities -$56.40M $0.00 -$300.0K
YoY Change 18700.0%
Cash From Investing Activities -$57.59M -$1.100M -$366.0K
YoY Change 15635.79% 450.0% -46.49%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 720.0K -33.20M 1.382M
YoY Change -47.9% 672.09% -191.04%
NET CHANGE
Cash From Operating Activities -2.290M 6.900M 40.54M
Cash From Investing Activities -57.59M -1.100M -366.0K
Cash From Financing Activities 720.0K -33.20M 1.382M
Net Change In Cash -59.16M -27.40M 41.55M
YoY Change -242.38% -141.64% -822.02%
FREE CASH FLOW
Cash From Operating Activities -$2.290M $6.900M $40.54M
Capital Expenditures $1.207M -$1.100M $46.00K
Free Cash Flow -$3.497M $8.000M $40.49M
YoY Change -108.64% -88.65% -1055.63%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14767769 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
19.41
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
600650 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
15.75
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
412500 shares
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
5.42
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1013150 shares
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
313761000
CY2014Q2 us-gaap Goodwill
Goodwill
18476000
CY2014Q2 us-gaap Assets
Assets
372317000
CY2014Q2 agx Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Stock Option Exercisable Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsStockOptionExercisableWeightedAverageGrantDateFairValue
5.81
CY2014Q2 agx Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Stock Option Outstanding Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsStockOptionOutstandingWeightedAverageGrantDateFairValue
5.65
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14672184 shares
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14668951 shares
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
23.92
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
707600 shares
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
21.01
CY2015Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
3233 shares
CY2015Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
225000 shares
CY2015Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
8.45
CY2015Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.15
CY2015Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2015Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2015Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
932600 shares
CY2015Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
187043000
CY2015Q2 us-gaap Billings In Excess Of Cost
BillingsInExcessOfCost
162973000
CY2015Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4455000
CY2015Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q2 us-gaap Liabilities Current
LiabilitiesCurrent
212410000
CY2015Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
503000
CY2015Q2 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
30000
CY2015Q2 us-gaap Common Stock Value
CommonStockValue
2201000
CY2015Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
29914000
CY2015Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
81117000
CY2015Q2 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
3048000
CY2015Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
110930000
CY2015Q2 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
3446000
CY2015Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19061000
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
194215000
CY2015Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
399872000
CY2015Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2039000
CY2015Q2 us-gaap Deferred Tax Liabilities Gross Current
DeferredTaxLiabilitiesGrossCurrent
462000
CY2015Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
4423000
CY2015Q2 us-gaap Deferred Tax Liabilities Gross Noncurrent
DeferredTaxLiabilitiesGrossNoncurrent
419000
CY2015Q2 us-gaap Minority Interest
MinorityInterest
-7172000
CY2015Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
4250000
CY2015Q2 us-gaap Line Of Credit
LineOfCredit
0
CY2015Q2 us-gaap Liabilities
Liabilities
212829000
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
274528000
CY2015Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1388000
CY2015Q2 us-gaap Goodwill
Goodwill
18476000
CY2015Q2 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
2025000
CY2015Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7606000
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
7823000
CY2015Q2 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
1106000
CY2015Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
3542000
CY2015Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
3824000
CY2015Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4340000
CY2015Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
337000
CY2015Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
283000
CY2015Q2 us-gaap Costs In Excess Of Billings On Uncompleted Contracts Or Programs
CostsInExcessOfBillingsOnUncompletedContractsOrPrograms
595000
CY2015Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1816000
CY2015Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
12061000
CY2015Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
7995000
CY2015Q2 us-gaap Assets
Assets
399872000
CY2015Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
-881000
CY2015Q2 us-gaap Short Term Investments
ShortTermInvestments
56017000
CY2015Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
34500000
CY2015Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1785000
CY2015Q2 us-gaap Treasury Stock Value
TreasuryStockValue
33000
CY2015Q2 us-gaap Assets Current
AssetsCurrent
372005000
CY2015Q2 agx Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Stock Option Exercisable Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsStockOptionExercisableWeightedAverageGrantDateFairValue
5.72
CY2015Q2 agx Line Of Credit Facility Designated To Cover Letters Of Credit
LineOfCreditFacilityDesignatedToCoverLettersOfCredit
1350000
CY2015Q2 agx Billings Contract Till Date
BillingsContractTillDate
633362000
CY2015Q2 agx Estimated Accrued Earnings
EstimatedAccruedEarnings
75776000
CY2015Q1 us-gaap Deferred Tax Liabilities Gross Noncurrent
DeferredTaxLiabilitiesGrossNoncurrent
809000
CY2015Q1 us-gaap Minority Interest
MinorityInterest
-10520000
CY2015Q1 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
176000
CY2015Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15976000
CY2015Q1 us-gaap Stockholders Equity
StockholdersEquity
185472000
CY2015Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
391193000
CY2015Q1 us-gaap Deferred Tax Liabilities Gross Current
DeferredTaxLiabilitiesGrossCurrent
201000
CY2015Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
4326000
CY2015Q2 agx Costs Incurred On Uncompleted Contracts
CostsIncurredOnUncompletedContracts
395208000
CY2015Q2 agx Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Stock Option Outstanding Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsStockOptionOutstandingWeightedAverageGrantDateFairValue
6.38
CY2015Q2 agx Number Of Joint Venture Under Contract With Company
NumberOfJointVentureUnderContractWithCompany
2 JointVenture
CY2015Q2 agx Uncompleted Contracts Revenue
UncompletedContractsRevenue
470984000
CY2015Q2 agx Accumulated Accrued Interest On Held To Maturity Securities
AccumulatedAccruedInterestOnHeldToMaturitySecurities
17000
CY2015Q2 agx Billings In Excess Of Cost On Uncompleted Contracts
BillingsInExcessOfCostOnUncompletedContracts
162378000
CY2015Q2 agx Maximum Amount Of Letters Of Credit
MaximumAmountOfLettersOfCredit
10000000
CY2015Q2 agx Deferred Tax Liabilities Construction Contracts
DeferredTaxLiabilitiesConstructionContracts
842000
CY2010Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
5500000
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
17.36
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
303000 shares
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
4.40
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
916150 shares
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
272209000
CY2014Q1 agx Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Stock Option Outstanding Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsStockOptionOutstandingWeightedAverageGrantDateFairValue
5.58
CY2015Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14634434 shares
CY2015Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14631201 shares
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
22.34
CY2015Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
3233 shares
CY2015Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
305500 shares
CY2015Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
7.14
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.15
CY2015Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2015Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2015Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
876350 shares
CY2015Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
174952000
CY2015Q1 us-gaap Billings In Excess Of Cost
BillingsInExcessOfCost
161564000
CY2015Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4396000
CY2015Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q1 us-gaap Liabilities Current
LiabilitiesCurrent
215432000
CY2015Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
533000
CY2015Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5500000
CY2015Q1 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
32000
CY2015Q1 us-gaap Common Stock Value
CommonStockValue
2195000
CY2015Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
37691000
CY2015Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
73614000
CY2015Q1 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
2931000
CY2015Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
109696000
CY2015Q1 us-gaap Line Of Credit
LineOfCredit
0
CY2015Q1 us-gaap Liabilities
Liabilities
216241000
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
333691000
CY2015Q1 us-gaap Goodwill
Goodwill
18476000
CY2015Q1 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
1786000
CY2015Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6518000
CY2015Q1 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
1132000
CY2015Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
3316000
CY2015Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1092000
CY2015Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
428000
CY2015Q1 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
107000
CY2015Q1 us-gaap Costs In Excess Of Billings On Uncompleted Contracts Or Programs
CostsInExcessOfBillingsOnUncompletedContractsOrPrograms
455000
CY2015Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1649000
CY2015Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10914000
CY2015Q1 us-gaap Assets
Assets
391193000
CY2015Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
-1010000
CY2015Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
27330000
CY2015Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1845000
CY2015Q1 us-gaap Treasury Stock Value
TreasuryStockValue
33000
CY2015Q1 us-gaap Assets Current
AssetsCurrent
364354000
CY2015Q1 agx Billings Contract Till Date
BillingsContractTillDate
546757000
CY2015Q1 agx Estimated Accrued Earnings
EstimatedAccruedEarnings
60809000
CY2015Q1 agx Costs Incurred On Uncompleted Contracts
CostsIncurredOnUncompletedContracts
324839000
CY2015Q1 agx Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Stock Option Outstanding Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsStockOptionOutstandingWeightedAverageGrantDateFairValue
6.01
CY2015Q1 agx Uncompleted Contracts Revenue
UncompletedContractsRevenue
385648000
CY2015Q1 agx Billings In Excess Of Cost On Uncompleted Contracts
BillingsInExcessOfCostOnUncompletedContracts
161109000
CY2015Q1 agx Deferred Tax Liabilities Construction Contracts
DeferredTaxLiabilitiesConstructionContracts
830000
CY2015Q2 agx Bankruptcy Claims Amount Received From Amount Of Claims Retained By Court
BankruptcyClaimsAmountReceivedFromAmountOfClaimsRetainedByCourt
1600000
CY2015Q1 us-gaap Payments Of Distributions To Affiliates
PaymentsOfDistributionsToAffiliates
25000000
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y15D
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y29D
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
CY2014Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
13.50
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.28
CY2014Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
383000 shares
CY2014Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
40536000
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0277 pure
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y9M22D
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
180500 shares
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
71000 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0126 pure
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y9M4D
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
3.27
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14683000 shares
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y11M23D
CY2014Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
27.09
CY2014Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.3383 pure
CY2014Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2014Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
83500 shares
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14299000 shares
CY2014Q2 us-gaap Income Tax Reconciliation Deductions
IncomeTaxReconciliationDeductions
715000
CY2014Q2 us-gaap Gross Profit
GrossProfit
10051000
CY2014Q2 us-gaap Contracts Revenue
ContractsRevenue
51191000
CY2014Q2 us-gaap Profit Loss
ProfitLoss
4800000
CY2014Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1846000
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6694000
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
6672000
CY2014Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
1587000
CY2014Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
22000
CY2014Q2 us-gaap Increase Decrease In Notes Receivables
IncreaseDecreaseInNotesReceivables
320000
CY2014Q2 us-gaap Increase Decrease In Cost In Excess Of Billing On Uncompleted Contract
IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract
-327000
CY2014Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
46000
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
3475000
CY2014Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5233000
CY2014Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1076000
CY2014Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3379000
CY2014Q2 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
254000
CY2014Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
60000
CY2014Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
41552000
CY2014Q2 us-gaap Cost Of Services
CostOfServices
41140000
CY2014Q2 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
2343000
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1894000
CY2014Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-366000
CY2014Q2 us-gaap Depreciation
Depreciation
142000
CY2014Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
343000
CY2014Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1382000
CY2014Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1128000
CY2014Q2 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
48000
CY2014Q2 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
300000
CY2014Q2 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
85000
CY2014Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1914000
CY2014Q2 us-gaap Increase Decrease In Billing In Excess Of Cost Of Earnings
IncreaseDecreaseInBillingInExcessOfCostOfEarnings
42781000
CY2014Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1325000
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1156000
CY2014Q2 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-34000
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.50
CY2015Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
11.48
CY2015Q2 dei Document Type
DocumentType
10-Q
CY2015Q2 dei Entity Registrant Name
EntityRegistrantName
ARGAN INC
CY2015Q2 dei Trading Symbol
TradingSymbol
AGX
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.55
CY2015Q2 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2015Q2 us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.0225 pure
CY2015Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
227000 shares
CY2015Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2290000
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0214 pure
CY2015Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y1M17D
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
6000 shares
CY2015Q2 us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2015-07-31
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
100000 shares
CY2015Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
180500 shares
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Method Used
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsMethodUsed
Black-Scholes option-pricing model
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0140 pure
CY2015Q2 dei Document Period End Date
DocumentPeriodEndDate
2015-04-30
CY2015Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3M26D
CY2015Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
6.28
CY2015Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
17.33
CY2015Q2 dei Amendment Flag
AmendmentFlag
false
CY2015Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
CY2015Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2015Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14864000 shares
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.51
CY2015Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y9M26D
CY2015Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
32.68
CY2015Q2 dei Entity Central Index Key
EntityCentralIndexKey
0000100591
CY2015Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2015Q2 us-gaap Line Of Credit Facility Interest Rate Description
LineOfCreditFacilityInterestRateDescription
LIBOR plus 2.25%
CY2015Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
37750 shares
CY2015Q2 us-gaap Variable Interest Entity Number Of Entities With Unavailability Of Information
VariableInterestEntityNumberOfEntitiesWithUnavailabilityOfInformation
2 Project
CY2015Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14637000 shares
CY2015Q2 us-gaap Income Tax Reconciliation Deductions
IncomeTaxReconciliationDeductions
1436000
CY2015Q2 us-gaap Gross Profit
GrossProfit
21167000
CY2015Q2 us-gaap Contracts Revenue
ContractsRevenue
85488000
CY2015Q2 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
56000000
CY2015Q2 us-gaap Profit Loss
ProfitLoss
10851000
CY2015Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3081000
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
15712000
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
15627000
CY2015Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
1434000
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.3463 pure
CY2015Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2015Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
40000 shares
CY2015Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
85000
CY2015Q2 us-gaap Increase Decrease In Notes Receivables
IncreaseDecreaseInNotesReceivables
386000
CY2015Q2 us-gaap Increase Decrease In Cost In Excess Of Billing On Uncompleted Contract
IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract
140000
CY2015Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1207000
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
7503000
CY2015Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7170000
CY2015Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-129000
CY2015Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5540000
CY2015Q2 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
286000
CY2015Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0
CY2015Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
60000
CY2015Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-59163000
CY2015Q2 us-gaap Cost Of Services
CostOfServices
64321000
CY2015Q2 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
5499000
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4861000
CY2015Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-57593000
CY2015Q2 us-gaap Depreciation
Depreciation
119000
CY2015Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
520000
CY2015Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
720000
CY2015Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
434000
CY2015Q2 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
102000
CY2015Q2 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
815000
CY2015Q2 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
1207000
CY2015Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4729000
CY2015Q2 us-gaap Increase Decrease In Billing In Excess Of Cost Of Earnings
IncreaseDecreaseInBillingInExcessOfCostOfEarnings
1409000
CY2015Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3348000
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
830000
CY2015Q2 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-17000
CY2015Q2 agx Short Term Investments Maturity Period
ShortTermInvestmentsMaturityPeriod
August to October 2015
CY2015Q2 agx Length Of Retention Period Of Amount Given To Project Owners
LengthOfRetentionPeriodOfAmountGivenToProjectOwners
P18M
CY2015Q2 agx Original Maturity Period Of Highly Liquid Investments
OriginalMaturityPeriodOfHighlyLiquidInvestments
Three months or less
CY2015Q2 agx Federal State And Local Income Tax Examination Applicability Description
FederalStateAndLocalIncomeTaxExaminationApplicabilityDescription
No longer subject to federal, state and local income tax examinations by tax authorities for its fiscal years ended on or before January 31, 2011 except for a few exceptions including California where the open period is one year longer.

Files In Submission

Name View Source Status
0001193125-15-216633-index-headers.html Edgar Link pending
0001193125-15-216633-index.html Edgar Link pending
0001193125-15-216633.txt Edgar Link pending
0001193125-15-216633-xbrl.zip Edgar Link pending
agx-20150430.xml Edgar Link completed
agx-20150430.xsd Edgar Link pending
agx-20150430_cal.xml Edgar Link unprocessable
agx-20150430_def.xml Edgar Link unprocessable
agx-20150430_lab.xml Edgar Link unprocessable
agx-20150430_pre.xml Edgar Link unprocessable
d924001d10q.htm Edgar Link pending
d924001dex311.htm Edgar Link pending
d924001dex312.htm Edgar Link pending
d924001dex321.htm Edgar Link pending
d924001dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g924001tx_logo.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending